Physician

Shaan Khan, M.D.

According to 2025 Medicare claims, Shaan Khan, M.D. (NPI: 1629488002) practices pain management in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is ADVANCED PAIN & ANESTHESIA CONSULTANTS, PC (NPI: 1457387078; TIN: 352062570) and primary practice location at 46350-5254.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 313 traditional Medicare patients, billed 15,922 HCPCS/CPT codes, and received $309,948 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 3,827 prescription claims across 421 beneficiaries totaling $101,042 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). Open Payments data shows 70 records totaling $5,259. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $19,723 to $309,948. Similarly, Part D prescription costs have risen steadily, from $551 to $101,042. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$155K$310K2019 Medicare payment: $19,723 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $83,849 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $91,476 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $152,361 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $170,183 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $309,948 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201957218$19,723
20201611,268$83,849
20212231,415$91,476
20222991,951$152,361
20233131,992$170,183
202431315,922$309,948

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$51K$101K2015 Drug cost: $551 (USD; Tot_Drug_Cst)2017 Drug cost: $438 (USD; Tot_Drug_Cst)2018 Drug cost: $14,528 (USD; Tot_Drug_Cst)2019 Drug cost: $41,749 (USD; Tot_Drug_Cst)2020 Drug cost: $53,021 (USD; Tot_Drug_Cst)2021 Drug cost: $68,635 (USD; Tot_Drug_Cst)2022 Drug cost: $69,455 (USD; Tot_Drug_Cst)2023 Drug cost: $71,955 (USD; Tot_Drug_Cst)2024 Drug cost: $101,042 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R16$551
2016N/RN/RN/R
2017N/R23$438
2018103197$14,528
2019188563$41,749
20201921,940$53,021
20212402,287$68,635
20222742,348$69,455
20232702,249$71,955
20244213,827$101,042

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
64483Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level113128$145
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more252863$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more178325$63
J1010Injection, methylprednisolone acetate, 1 mg10110,959$0
J1100Injection, dexamethasone sodium phosphate, 1 mg1131,767$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen83223,046$18,279
PregabalinPregabalin43713,921$11,676
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen41211,821$10,819
OxycontinOxycodone Hcl24702$8,291
CelecoxibCelecoxib1133,900$6,334

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.70$5,259Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shaan Khan, M.D.?

Tedicare shows public-source Medicare data for Shaan Khan, M.D. (NPI 1629488002), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shaan Khan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shaan Khan, M.D.?

Shaan Khan, M.D. is linked to ADVANCED PAIN & ANESTHESIA CONSULTANTS, PC (billing NPI 1457387078) in the available physician profile data.

Does Shaan Khan, M.D. have Open Payments data?

Shaan Khan, M.D. has 70 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.